Prostate News Archive
23-Jul-2006
Ex-NHS adviser slams cancer care lottery (The Observer)
The row over the rationing of prostate-cancer therapy deepened this weekend, as the government's former chief economic adviser on the NHS revealed that he had received the treatment only after threatening to publicise the fact that its use was being restricted. Biomira Stimuvax(R) (L-BLP25) Prostate Cancer Study Results Published (CNW Group via Yahoo! Finance)
Biomira Inc. , today announced publication of study results showing that Stimuvax, formerly known as BLP25 Liposome Vaccine or L-BLP25, could slow rising prostate Specific Antigen levels in some post-surgical prostate cancer patients, potentially delaying the need for initiation of androgen deprivation therapy . Basketball events providing assists in spreading awareness (Dallas Morning News)
If not for his wife's persistence, Ed Sanders believes he might not be alive today. Analysis: Prostate Drug for Alzheimer's? (RedNova)
By ED SUSMAN Voyager Pharmaceutical Corp.'s investigational drug -- commonly used to treat prostate cancer -- received mixed results Wednesday from its phase 2 study in the treatment of men and women with mild-to-moderate Alzheimer's disease. There's just one subject left that you can't talk about (Pioneer Press)
This is such a sensitive subject. These days, you can talk about people's medical problems, their colons and their prostate glands and their breasts; you can talk about their kids' disabilities, Britney's ADHD and the twins' various leanings on the autistic spectrum; you can talk about people's sexual preferences and their parents' alcoholism and their battles with depression, bulimia and/or Biomira Stimuvax prostate cancer study results published (News-Medical-Net)
Biomira Inc. has announced publication of study results showing that Stimuvax, formerly known as BLP25 Liposome Vaccine or L-BLP25, could slow rising prostate Specific Antigen (PSA) levels in some post-surgical prostate cancer patients
Back to Prostate News Archive
